Ra Capital Management, L.P. - Nov 8, 2022 Form 3 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Director
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
SPRY
Transactions as of
Nov 8, 2022
Transactions value $
$0
Form type
3
Date filed
11/10/2022, 04:00 PM
Previous filing
Oct 24, 2022
Next filing
Nov 9, 2022

No securities are beneficially owned.

Remarks:

Dr. Peter Kolchinsky, a Managing Partner of RA Capital Management, L.P., serves on the Issuer's board of directors.